Planning

Ambroxol drug trial

  • Sheffield Teaching Hospitals NHS Foundation Trust

F01: Prior information notice (prior information only)

Notice identifier: 2025/S 000-001377

Procurement identifier (OCID): ocds-h6vhtk-04d045

Published 15 January 2025, 2:28pm



Section one: Contracting authority

one.1) Name and addresses

Sheffield Teaching Hospitals NHS Foundation Trust

Royal Hallamshire Hospital, Glossop Road

Sheffield

S10 2JF

Contact

Andrew Duffield

Email

a.duffield1@nhs.net

Telephone

+44 7790363970

Country

United Kingdom

Region code

UKE32 - Sheffield

Internet address(es)

Main address

https://www.sth.nhs.uk

Buyer's address

https://www.sth.nhs.uk

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Ambroxol drug trial

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

We seek indicative costs from Suppliers who have the capability to purchase or manufacture Ambroxol 420mg tablets for a clinical trial.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 85149000 - Pharmacy services

two.2.3) Place of performance

NUTS codes
  • UKE32 - Sheffield

two.2.4) Description of the procurement

We seek indicative costs from Suppliers who have the capability to purchase or manufacture Ambroxol 420mg tablets for a clinical trial.
Approximately 44,160 tablets for up to 80 participants will be required for distribution to 11 UK sites, 4 times per year for 2 years. Drugs to be distributed in blister packs.
Indicative costs also required for the production and distribution of an Investigator brochure for the above.
Any indicative costs provided through this Prior Information notice will be used soley to apply for funding for this project and will not be evaluated in any further procurement activity.
We would also like to understand what the supply market looks like, how many suppliers could meet our requirements and what sort of time frames might be required to produce these quantities of Ambroxol.
Funding approval will be required prior to any Tendering exercise and any procurement would also be dependent on regulatory approval from MHRA.
Please note this is not a call for competition but for market engagement purposes only and any pricing received at this stage will have no bearing on any future procurement evaluation.

two.3) Estimated date of publication of contract notice

15 January 2025


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes